Full-Time Equivalent(FTE)

Medicilon offers FTE services for clients in collaboration with our dedicated R&D and project management team. According to customer requirements, it can configure different proportions of R&D staff with different levels of Ph.D., M.S., or B.S. degrees to form a joint R&D team with customers. This team efficiently solves technical problems in their R&D projects, and provides regular project progress reports and project communication meetings.

Download

In the early stages of new drug development, FTE (Full-time equivalent) is often used by drug discovery companies to synthesize required structural fragments and/or potential candidate compounds, accelerating the drug screening process. Medicilon offers comprehensive chemistry research services across all project stages, with customers able to collaborate through the FFS (Fee for Service) or FTE (Full-time Equivalent Service) models.
Moreover, Medicilon can quickly adapt to clients' needs and provide efficient output to ensure the smooth progress of projects. This partnership model is ideal for innovative drug development projects.
The Medicilon Chemical FTE team can assist clients at different stages of drug development, including:
Generation and optimization of lead compoundsCompound identificationOptimization and scale-up synthesis of lead compoundsChemical process studies

FTE Collaboration Model
This collaboration model allows for flexible adjustment of R&D staffing, experimental protocols, and project priorities based on client and project needs.
FTE Service Advantages
The research department will communicate with customers when encountering problems in the R&D process and propose solutions to resolve them. In addition, the FTE team synthesizes according to the synthesis line designed by the customer and also designs the synthesis line based on the customer's concept.
Flexible adjustments based on project requirements ensure clear and manageable project progress, providing exclusive synthesis circuit design and problem-solving capabilities, all of which reflect the service advantages of the Medicilon FTE team.
FTE Service Scope
Medicinal Chemistry
Synthetic Chemistry
Analytical Chemistry
FTE Service Cases
Driven by customers’ needs and with a mission of innovative drug research, the Medicilon Chemical FTE team has supported numerous companies in drug development.
The RG001 tablet is a new SHP2 allosteric inhibitor independently developed by Ringene using structural biology and drug metabolism-oriented drug design methods. Medicilon provided a range of preclinical services for the development of RG001 tablets, from drug target identification to IND filing, preparing them for clinical trials. These services included drug discovery, pharmaceutical research, and pre-clinical research (drug efficacy and safety evaluations).
Learn more
ABM Therapeutics has been collaborating with Medicilon since 2016. During this partnership, Medicilon’s FTE team assisted ABM Therapeutics in discovering the clinical candidate compound (PCC) ABM-1310, which is currently undergoing simultaneous clinical trials in China and the United States.
MindRank, an AI pharmaceutical company, collaborated with Medicilon’s FTE services to combine AI design with laboratory confirmation effectively. In a short-term, cost-effective and high-efficient mode of operation, Medicilon successfully completed the collaborative project with high quality, earning the "2021 Excellent Team Award" from the customer.
Learn more

Inquire

Relevant laboratories

Relevant articles

Medicinal Chemistry Analytical Chemistry Catalyst Screening Enzyme Catalysis Full-Time Equivalent(FTE) Fee For Service(FFS)